Literature DB >> 26065339

Insulinlike growth factor I improves yak (Bos grunniens) spermatozoa motility and the oocyte cleavage rate by modulating the expression of Bax and Bcl-2.

Yangyang Pan1, Yan Cui1, Abdul Rasheed Baloch2, Jiangfeng Fan1, Junfeng He1, Guyue Li1, Hongfei Zheng1, Yifu Zhang1, Peng Lv1, Sijiu Yu3.   

Abstract

The aim of our present study was to examine the effects of insulinlike growth factor 1 (IGF-1) on yak sperm motility during in vitro capacitation and the relationship between the effects of IGF-1 on yak sperm motility and apoptosis was evaluated. Frozen-thawed yak spermatozoa were incubated at 38 °C for 1 hour in Tyrode's bicarbonate-buffered medium for sperm culture (Sp-TALP) with different concentrations (0, 50, 100, and 200 ng/mL) of IGF-1. In every treatment, the sperm motility was measured by a computer-assisted sperm analyzer system. The fertilizing ability of spermatozoa was evaluated on the basis of oocyte cleavage rate after insemination. The expression of Bax and Bcl-2 was examined by real-time polymerase chain reaction and Western blot for the messenger RNA and protein levels. It is interesting to note that IGF-1 improved yak spermatozoa motility and the cleavage rate of oocytes; these improvements were highest in the 100 ng/mL IGF-1 group, followed by the 200 ng/mL and 50 ng/mL groups, with the lowest improvements in motility and cleavage rates in groups without IGF-1. The expression level of Bax was downregulated by IGF-1, whereas Bcl-2 was upregulated. Both messenger RNA and Bax proteins were lowest in groups with 100 ng/mL IGF-1, where the Bcl-2 was the highest. Bax expression in the groups with IGF-1 was lower than that in the group without IGF-1, and Bcl-2 expression was higher in groups with IGF-1 than that in the group without IGF-1. In conclusion, this research reports that improvements in yak spermatozoa motility and the oocyte cleavage rate after the addition of IGF-I may be a result of the reduction of spermatozoa apoptosis rates by modulating the expression of Bax and Bcl-2.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bax; Bcl-2; Insulinlike growth factor 1; Motility; Spermatozoon; Yak

Mesh:

Substances:

Year:  2015        PMID: 26065339     DOI: 10.1016/j.theriogenology.2015.05.007

Source DB:  PubMed          Journal:  Theriogenology        ISSN: 0093-691X            Impact factor:   2.740


  5 in total

1.  Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1.

Authors:  Chun-Li Song; Bin Liu; Hong-Ying Diao; Yong-Feng Shi; Ji-Chang Zhang; Yang-Xue Li; Ning Liu; Yun-Peng Yu; Guan Wang; Jin-Peng Wang; Qian Li
Journal:  Oncotarget       Date:  2016-06-28

2.  The use of insulin-like growth factor 1 improved the parameters of the seminogram in a patient with severe oligoasthenoteratozoospermia.

Authors:  José Arturo Mora Rodríguez; Leonardo M Porchia; Felipe Camargo; Esther López-Bayghen
Journal:  SAGE Open Med Case Rep       Date:  2019-03-05

3.  Estrogen improves the development of yak (Bos grunniens) oocytes by targeting cumulus expansion and levels of oocyte-secreted factors during in vitro maturation.

Authors:  Yangyang Pan; Meng Wang; Libin Wang; Qian Zhang; Abdul Rasheed Baloch; Honghong He; Gengquan Xu; Jamila Soomro; Yan Cui; Sijiu Yu
Journal:  PLoS One       Date:  2020-09-17       Impact factor: 3.240

4.  Effects of substituting soybean meal with corn on immune function and gene expression of gut TLR4 pathway of growing goats.

Authors:  Yan Cheng; Chao Yang; Wenxun Chen; Qiongxian Yan; Zhiliang Tan; Zhixiong He
Journal:  PeerJ       Date:  2022-02-07       Impact factor: 2.984

5.  Leukemia inhibitory factor enhances the development and subsequent blastocysts quality of yak oocytes in vitro.

Authors:  Tian Zhao; Yangyang Pan; Qin Li; Tianyi Ding; Robert Niayale; Tongxiang Zhang; Jinglei Wang; Yaying Wang; Ling Zhao; Xiaohong Han; Abdul Rasheed Baloch; Yan Cui; Sijiu Yu
Journal:  Front Vet Sci       Date:  2022-09-21
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.